Inventor
HOOK MAGNUS
35 patents
⚠️ This page may combine multiple inventors who share the name “HOOK MAGNUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEXAS A & M UNIV SYS
16 patentsUS5648240AJul 15, 1997
MHC II analog from Staphylococcus aureus
TEXAS A & M UNIV SYS109 citations93
US6312907B1Nov 6, 2001
DbpA compositions and methods of use
TEXAS A & M UNIV SYS31 citations90
US7615616B2Nov 10, 2009
Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
TEXAS A & M UNIV SYS14 citations89
US5853987ADec 29, 1998
Decorin binding protein compositions and methods of use
TEXAS A & M UNIV SYS29 citations89
US10358464B2Jul 23, 2019
Specific binding sites in collagen for integrins and use thereof
TEXAS A & M UNIV SYS8 citations83
US7850974B2Dec 14, 2010
Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
TEXAS A & M UNIV SYS9 citations81
US9725498B2Aug 8, 2017
Designer collagens and use thereof
TEXAS A & M UNIV SYS9 citations77
US6214355B1Apr 10, 2001
DbpA compositions
TEXAS A & M UNIV SYS12 citations71
US7153515B2Dec 26, 2006
Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus
TEXAS A & M UNIV SYS2 citations63
US6248517B1Jun 19, 2001
Decorin binding protein compositions and methods of use
TEXAS A & M UNIV SYS5 citations60
US11597756B2Mar 7, 2023
Designer collagens and use thereof
TEXAS A & M UNIV SYS0 citations56
US11041003B2Jun 22, 2021
Crystal structure of Staphylococcus aureus clumping factor A in complex with fibrinogen derived peptide and uses thereof
TEXAS A & M UNIV SYS0 citations56
US12023419B2Jul 2, 2024
Prokaryotic collagen therapeutics for postoperative adhesions
TEXAS A & M UNIV SYS1 citations50
US11446371B2Sep 20, 2022
Targeting of ligand binding sites in ClfA
TEXAS A & M UNIV SYS0 citations49
US11407819B2Aug 9, 2022
Compositions and use of a fibrinogen binding motif present in EFB and COA for therapeutics and vaccines against Staphylococcus aureus
TEXAS A & M UNIV SYS0 citations49
US7638135B2Dec 29, 2009
Collagen-binding proteins from enterococcal bacteria
TEXAS A & M UNIV SYS0 citations46
INHIBITEX INC
5 patentsUS6703025B1Mar 9, 2004
Multicomponent vaccines
INHIBITEX INC91 citations97
US6692739B1Feb 17, 2004
Staphylococcal immunotherapeutics via donor selection and donor stimulation
INHIBITEX INC113 citations97
US7045131B2May 16, 2006
Staphylococcal immunotherapeutics via donor selection and donor stimulation
INHIBITEX INC46 citations96
US7666438B1Feb 23, 2010
Multicomponent vaccines
INHIBITEX INC24 citations92
US7241592B2Jul 10, 2007
Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
INHIBITEX INC1 citations46
ALFA LAVAL AGRI INT
4 patentsUS5840846ANov 24, 1998
Fibronectin binding protein as well as its preparation
ALFA LAVAL AGRI INT85 citations94
US5416021AMay 16, 1995
Fibronectin binding protein-encoding DNA
ALFA LAVAL AGRI INT40 citations92
US6086895AJul 11, 2000
Fibronectin binding protein
ALFA LAVAL AGRI INT24 citations90
US5866541AFeb 2, 1999
Fibronection binding protein from Streptococcus dysgalactiae
ALFA LAVAL AGRI INT17 citations90
ALFA LAVAL AB
2 patentsUS5980908ANov 9, 1999
Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
ALFA LAVAL AB45 citations90
US5851794ADec 22, 1998
Collagen binding protein as well as its preparation
ALFA LAVAL AB24 citations87
UNIV TEXAS
2 patentsHOEOEK MAGNUS
2 patentsUS8280643B2Oct 2, 2012
Crystal structure of Staphylococcus aureus clumping factor A in complex with fibrinogen derived peptide and uses thereof
HOEOEK MAGNUS8 citations77
US8124107B2Feb 28, 2012
Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use
HOEOEK MAGNUS8 citations73